News about Silicon Valley business almost everyday.
SOUTH SAN FRANCISCO – Arsenal Biosciences, a clinical stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid tumors, announced the close of an oversubscribed $325 million Series C financing round. The funding round included new investors ARCH Venture Partners, Milky Way Investments Group, Regeneron Ventures, NVentures (NVIDIA’s venture capital arm), […]
SAN FRANCISCO — Agree, an all-in-one agreements platform that seamlessly integrates money movement, has announced a $3 million pre-seed round. The round was led by Better Tomorrow Ventures with participation from 8-Bit Capital, Everywhere Ventures, Expedite Ventures, Firsthand Alliance, Hustle Fund, NEA, Singh Capital Partners, and Trust Fund. With this investment, the company aims to […]
SAN FRANCISCO — Opkey, an Artificial Intelligence (AI) continuous test automation platform for enterprise systems, has raised $47 million in Series B funding led by PeakSpan Capital, with continued support from existing investors. This substantial investment will fuel Opkey’s mission to deliver continuous assurance and streamline cloud Enterprise Resource Planning (ERP) transformation programs, enabling Opkey to accelerate product development, […]
SAN FRANCISCO — Thatch, a personalized health benefits platform for businesses, has raised $38 million in Series A funding. The round was led by Index Ventures and General Catalyst, along with new investors SemperVirens and The General Partnership, with participation from existing investors including Andreessen Horowitz (a16z) and Avid Ventures. This investment will fuel Thatch’s mission […]
PALO ALTO — Drip Capital, a digital platform for trade finance, has secured $113 million in new funding. This includes $23 million in equity from Japanese institutional investors, GMO Payment Gateway and Sumitomo Mitsui Banking Corporation (SMBC), and $90 million in debt financing, led by the International Finance Corporation (IFC) and East West Bank. The company collaborates with over 9,000 sellers and […]
MOUNTAIN VIEW — Codeium, an AI-powered code acceleration platform, has secured $150 million in Series C funding, raising the company’s valuation to $1.25 billion and bringing the startup to Unicorn status in less than two years from inception. The round was led by General Catalyst, with continued support from existing investors Kleiner Perkins and Greenoaks. […]
SAN FRANCISCO –Openwater announced the acceleration of its plans to commercialize its hospital-grade technology platform that integrates semiconductor physics, light, and sound to diagnose and treat diseases at the cellular level. The company, founded by brain tumor survivor and former Google X, Meta, and “One Laptop Per Child” executive Mary Lou Jepsen, has secured $100 […]
UNION CITY — XII Medical, Inc., a clinical-stage medical technology company developing innovative therapies for obstructive sleep apnea, has closed a $45 million Series B equity financing. The financing was led by Omega Funds and joined by new investor Intuitive Ventures. Existing investors also participated, including founding investor Cleveland Clinic, Ajax Health, Longview Ventures (an […]
FREMONT – Moximed, a medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), has closed on $61 million of Series D preferred stock financing with an option to close on up to an additional $30 million. The round was led by Elevage Medical Technologies, a Patient […]
SAN FRANCISCO — Encord, an AI data development platform for advanced vision and multimodal teams, has announced a $30 million Series B funding. The round was led by Next47, a global venture firm investing in early and expansion-stage companies in SaaS, AI and enterprise, with participation from existing investors Y Combinator, CRV, and Crane Venture […]
BURLINGAME — Neptune Medical, a developer of advanced medical devices with a primary focus on gastrointestinal robotics, has announced the successful spinout of its subsidiary, Jupiter Endovascular, following the completion of a $97 million Series D financing. Sonder Capital and Olympus Corporation of the Americas were significant participants in this round, along with investments from […]
MENLO PARK –Jupiter Endovascular, Inc., a medical technology startup developing a new class of endovascular procedures using Endoportal Control to bring the precision and control of direct surgical access to catheter-based interventions, has exited stealth mode with a $21 million new round of financing. Sonder Capital was a key participant in the round that included […]